Loading clinical trials...
Loading clinical trials...
Effect and Safety of PCSK9 Inhibitors on the Progression of Mild/Middle Calcific Aortic Stenosis: A Randomized Controlled Clinical Trial
Conditions
Interventions
Treatment with PCSK9 inhibitors
Treatment without PCSK9 inhibitors
Locations
1
China
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Start Date
January 1, 2026
Primary Completion Date
December 31, 2028
Completion Date
January 31, 2029
Last Updated
December 30, 2025
NCT03585933
NCT03088787
Lead Sponsor
Beijing Anzhen Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions